Office-use compounding in Kansas

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The permission does not split on sterility, and that is the findingHigh confidence

The sterile and non-sterile rules are the same sentence with one adjective changed. Other states reviewed here reach sterile product too, but they do it through a grant written in class-neutral terms or through a separate sterile rule that has to be read across; Kansas wrote the permission twice, once in each rule, so a compounded injectable is inside it on the sterile rule’s own words rather than by inference. Some states in this file — Illinois and Connecticut among them — permit the non-sterile half and stop, which is why the limb has to be checked rather than assumed.

What the permission does not reachHigh confidence

It is a grant of Kansas law and nothing more. Neither subsection contains a federal-compliance condition, a reference to the federal compounding statute, or an FDA hook of any kind. That makes the grant genuinely effective as Kansas law and leaves 21 U.S.C. § 353a exactly where it found it — office stock is not compounded for an identified individual patient on a valid prescription order, so the federal exemptions are not engaged. Both are true at once.

A mandatory label legend, on both limbsHigh confidence

Kansas requires the words "For Office Use Only — Not for Resale." on the non-sterile limb and "For Office Use Only — Not For Resale." on the sterile one. The difference in capitalisation between the two rules is real and is reproduced here as the state wrote it; the separator is an em dash.

Controlled substances are re-channelled, not prohibited — the obvious errorHigh confidence

A pharmacist may not fill a PRESCRIPTION for a controlled substance or drug of concern for office use, but may document on an INVOICE any distribution of those items to a registrant. That is a rule about which instrument documents the transfer, not a bar on the transfer. Kansas also applies it to "drugs of concern", a category most states do not maintain at all.Reading this subsection as a ban on controlled-substance office stock is the single most likely Kansas mistake, and it is the sort a supplier or a competitor page makes while quoting the first sentence and stopping. The two sentences are one rule.

Two asymmetries between the limbs that are easy to smooth awayHigh confidence

The permission does not split, but its neighbouring duties do. The four-element invoice duty sits in the non-sterile rule only — the word "invoice" does not appear in the sterile rule at all — and the commercial-availability gates in the two rules are not the same. A page that treats the two limbs as interchangeable in every respect will state the paperwork wrong for sterile product.

Quantity — a phrase, not a numberHigh confidence

Each rule uses "limited quantities" twice and defines it nowhere. Searches for "inordinate" and for a reasonable-quantity standard return nothing across the whole agency rule corpus. There is no percentage, no day-supply and no per-practitioner ceiling to measure against.

Entity or person — different qualifying concepts for the two drug classesHigh confidence

For non-controlled drugs the possession exemption at K.S.A. 65-1635(a) lets "any duly licensed practitioner" purchase and keep drugs, which is a natural person, and no clinic-entity credential exists to obtain. The controlled-substance route runs instead to a "registrant", which is a registration-based concept rather than a personal one. The two classes therefore qualify on different footings in the same state.

Last changeHigh confidence

Both compounding rules took effect 11 May 2018 and each carries the state’s own authenticated-regulation marker. The rules database reports a single version, currently effective and active.

Kansas at a glance

Receiving 503B office stock in Kansas

Kansas is one of the states where searching for the literal term works, and its outsourcing-facility trigger is unusually broad — it names drugs without qualifying them as sterile, patient-specific or human. The receiving practice needs nothing, and the reason matters: nothing is available rather than nothing being required.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Kansas asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

An outsourcing facility registration from the Board of Pharmacy, $350 new and $350 on renewal, required for each separate place of business. The fee rule also names a "virtual outsourcing facility". The statutory trigger at K.S.A. 65-1643(n) speaks of drugs without limiting them to sterile, patient-specific or human product, so it is wider than most states’ equivalents.One budgeting trap: the legislature authorised a nonresident surcharge in 2021, of up to $350 new and $250 on renewal, and it has never been written into the fee rule — that rule predates the statute by two years. If the Board adopts it, out-of-state costs roughly double. Whether the Board charges it administratively could not be confirmed, because its website was unreachable throughout this research.

Does your practice need a permit?High confidence

No — and the distinction is worth stating precisely: there is nothing available, not merely nothing required. K.S.A. 65-1635(a) lets a practitioner purchase and keep drugs, and the one facility category that might otherwise catch a clinic expressly excludes it.

Administer vs dispenseHigh confidence

The permission itself is written around administration: the pharmacy may supply limited quantities for the practitioner to administer to an individual patient, and the preparations may not be intended for resale. Nothing in the rule authorises handing the product to the patient.

Scheduled (controlled) stockMedium confidence

Kansas registers controlled substances and separately maintains a "drugs of concern" category, and that second category is what feeds the invoice-to-registrant channel rule. For this vertical the point is usually moot — compounded peptides and hormones are legend drugs rather than scheduled substances — but where a shipment does carry controlled items, the documentation route changes rather than closing.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• The Kansas Board of Pharmacy’s own website was unreachable throughout this research — every address returned an access error, to every client tried including a real browser. So no board newsletter, FAQ, guidance document or set of minutes was reviewed for the state carrying the most commercially important permission on this site. A board newsletter narrowing "limited quantities", or an inspection position on the sterile invoice asymmetry, would sit squarely on this page. Treat that as the largest open item here.
• Whether the Board administratively charges the nonresident surcharge the legislature authorised in 2021 is unconfirmed, because of the same unreachable site. Anyone budgeting an out-of-state registration should call the Board rather than rely on the published fee.
• One parsing hazard worth knowing if you check this yourself: the Secretary of State’s "future effective regulations" page carries a sentence inside an HTML comment saying there are none, while the live content says the opposite. A naive read of that page flips its meaning exactly.
• We searched no case law, attorney-general opinions or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.